1271 - 1280 of 7939 Results
Title
Year
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 4
-
OPENTitle: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and functionJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113896End Page: 113896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896Citation Count: 8
-
OPENTitle: Cortico-Subthalamic Field Potentials Support Classification of the Natural Gait Cycle in Parkinson’s Disease and Reveal Individualized Spectral SignaturesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 6Start Page: ENEURO.0325End Page: 22.2022Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0325-22.2022Best OA location URL: https://www.eneuro.org/content/eneuro/9/6/ENEURO.0325-22.2022.full.pdfCitation Count: 5
-
OPENTitle: Neuromelanin and T2*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00405-9Best OA location URL: https://www.nature.com/articles/s41531-022-00405-9.pdfCitation Count: 9
-
OPENTitle: A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 213End Page: 222Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13603Citation Count: 1
-
OPENTitle: Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 68End Page: 81Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29257Best OA location URL: https://doi.org/10.1002/mds.29257Citation Count: 27
-
OPENTitle: Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesiaJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.846126Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.846126/pdfCitation Count: 2
-
OPENTitle: Cognitive dysfunction 1 year after COVID‐19: evidence from eye trackingJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 11Start Page: 1826End Page: 1831Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51675Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51675Citation Count: 8
-
RESTRICTEDTitle: Genetic architecture of Parkinson’s disease subtypes – Review of the literatureJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1023574Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1023574/pdfCitation Count: 19
-
OPENTitle: Identification of cholinergic centro-cingulate topography as main contributor to cognitive functioning in Parkinson’s disease: Results from a data-driven approachJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1006567Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1006567/pdfCitation Count: 6